Dr. med. Ugur Uslu

Department of Dermatology Interdisziplinäres Zentrum für Klinische Forschung IZKF-Förderlinien

Fumaric Acid Esters and TNF alpha Inhibitors - Do they affect the Fertility of male Patients with Psoriasis? (2017) Heppt F, Colsmann A, Maronna A, Uslu U, Heppt M, Kiesewetter F, Sticherling M Conference contribution The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma (2017) Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, et al. Conference contribution Influence of TNF-alpha inhibitors and fumaric acid esters on male fertility in psoriasis patients (2017) Heppt F, Colsman A, Maronna A, Uslu U, Heppt MV, Kiesewetter F, Sticherling M Journal article Factors Influencing Disease Progression in Patients with Head and Neck Melanoma (2017) Uslu U, Schuler G, Breuninger H Journal article Secondary syphilis infection under treatment with ustekinumab (2017) Uslu U, Heppt F, Sticherling M Journal article Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells (2017) Uslu U, Schliep S, Schliep K, Erdmann M, Koch HU, Parsch H, Rosenheinrich S, et al. Journal article Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma. (2016) Uslu U, Schuler G, Dörrie J, Schaft N Journal article gamma/delta T cells RNA-transfected with a T-cell receptor and a chimeric antigen receptor specific for melanoma (2016) Harrer D, Simon B, Schuler G, Uslu U, Hoyer S, Dörrie J, Schaft N Conference contribution Combining a CAR and a TCR to generate T cells expressing two additional receptors (TETARs) for melanoma immunotherapy (2016) Uslu U, Gerer K, Hoyer S, Schuler G, Dörrie J, Schaft N Conference contribution